Literature DB >> 18031972

Implementing a hospital-based smoking cessation programme: evidence for a learning effect.

Tobias Raupach1, Lion Shahab, Karin Neubert, Dorothea Felten, Gerd Hasenfuss, Stefan Andreas.   

Abstract

OBJECTIVE: This study assessed a newly set-up, hospital-based smoking cessation clinic with regard to continuous abstinence rates and the effectiveness of concomittant nicotine replacement therapy.
METHODS: Smoking status of 369 participants of this 8-week cognitive-behavioural smoking cessation group programme was obtained using exhaled carbon monoxide at the end of the course as well as self-report 6 months after the course. In addition to demographic data, FTND score, SDS score, and usage of nicotine replacement products were recorded.
RESULTS: Overall, 29.8% of all participants reported to have been continuously abstinent for 6 months after the course. Success rates increased significantly during the first year after initiation of the programme (from 15 to 35%, p<0.001), indicating a learning process of the staff running the course. Nicotine replacement therapy was used by 51.3% of participants, but 58% of these discontinued its use within 5 weeks. Nicotine substitution for more than 5 weeks was associated with a 50% success rate after 6 months.
CONCLUSIONS: Our data indicate a learning effect of smoking cessation course staff and a possible minimum duration required for nicotine replacement to be effective. PRACTICE IMPLICATIONS: The observed learning effect in smoking cessation programmes should be considered when evaluating newly established interventions of this kind. Patients tend to stop nicotine replacement therapy too early, thereby decreasing their chances of middle-term abstinence.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18031972     DOI: 10.1016/j.pec.2007.10.005

Source DB:  PubMed          Journal:  Patient Educ Couns        ISSN: 0738-3991


  6 in total

1.  Electronically Monitored Nicotine Gum Use Before and After Smoking Lapses: Relationship With Lapse and Relapse.

Authors:  Tanya R Schlam; Timothy B Baker; Stevens S Smith; Daniel M Bolt; Danielle E McCarthy; Jessica W Cook; Todd Hayes-Birchler; Michael C Fiore; Megan E Piper
Journal:  Nicotine Tob Res       Date:  2020-10-29       Impact factor: 4.244

2.  Assessment of variables associated with smoking cessation in Crohn's disease.

Authors:  Yvette Leung; Gil G Kaplan; Kevin P Rioux; James Hubbard; Sarah Kamhawi; Lidia Stasiak; Russell D Cohen; Shane M Devlin; Remo Panaccione; Stephen B Hanauer; David T Rubin
Journal:  Dig Dis Sci       Date:  2012-02-07       Impact factor: 3.199

Review 3.  [Smoking cessation with nicotine replacement therapy (NRT) - a scientific update].

Authors:  Karl-Heinz Mulzer; Alfred Lichtenschopf; Irmgard Homeier; Ernest Groman
Journal:  Wien Med Wochenschr       Date:  2009

4.  Association between duration of use of pharmacotherapy and smoking cessation: findings from a national survey.

Authors:  Mohammad Siahpush; Raees A Shaikh; Molly McCarthy; Asia Sikora Kessler; Melissa Tibbits; Gopal K Singh
Journal:  BMJ Open       Date:  2015-01-13       Impact factor: 2.692

5.  A surgeon led smoking cessation intervention in a head and neck cancer centre.

Authors:  Ming Wei Tang; Richard Oakley; Catherine Dale; Arnie Purushotham; Henrik Møller; Jennifer Elizabeth Gallagher
Journal:  BMC Health Serv Res       Date:  2014-12-20       Impact factor: 2.655

6.  Effects of varenicline on sympatho-vagal balance and cue reactivity during smoking withdrawal: a randomised placebo-controlled trial.

Authors:  Helge Haarmann; Alexandra Gossler; Peter Herrmann; Slavtcho Bonev; Xuan Phuc Nguyen; Gerd Hasenfuß; Stefan Andreas; Tobias Raupach
Journal:  Tob Induc Dis       Date:  2016-08-08       Impact factor: 2.600

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.